Empagliflozin and linagliptin and Insulin glargine and lixisenatide
Determining the interaction of Empagliflozin and linagliptin and Insulin glargine and lixisenatide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: empagliflozin / linagliptin
Brand name: Glyxambi
Synonyms: Empagliflozin and Linagliptin
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Empagliflozin and linagliptin-Insulin glargine and lixisenatide Subcutaneous
- Empagliflozin and linagliptin-Insulin glargine, recombinant Subcutaneous
- Empagliflozin and linagliptin-Insulin glulisine
- Empagliflozin and linagliptin-Insulin Glulisine (Cartridges and Pens)
- Empagliflozin and linagliptin-Insulin Glulisine (Vials)
- Empagliflozin and linagliptin-Insulin glulisine Subcutaneous
- Insulin glargine and lixisenatide-Empagliflozin and metformin
- Insulin glargine and lixisenatide-Empagliflozin and Metformin Extended-Release Tablets
- Insulin glargine and lixisenatide-Empagliflozin and Metformin Tablets
- Insulin glargine and lixisenatide-Empliciti
- Insulin glargine and lixisenatide-Emsam
- Insulin glargine and lixisenatide-Emsam Transdermal